These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10580185)

  • 1. Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia.
    Sumino H; Nakamura T; Ichikawa S; Kanda T; Sakamaki T; Sato K; Kobayashi I; Nagai R
    Atherosclerosis; 2000 Jan; 148(1):189-95. PubMed ID: 10580185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
    Agrawal R; Prelevic G; Conway GS; Payne NN; Ginsburg J; Jacobs HS
    Fertil Steril; 2000 Jan; 73(1):56-60. PubMed ID: 10632412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
    Denke MA
    Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.
    Tamama K; Sumino H; Ichikawa S; Kanda T; Kotajima N; Fukumura Y; Kurabayashi M; Murakami M
    J Hypertens; 2003 Jun; 21(6):1151-6. PubMed ID: 12777952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal women.
    Sumino H; Ichikawa S; Yoshida A; Murakami M; Kanda T; Mizunuma H; Sakamaki T; Kurabayashi M
    Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1044-51. PubMed ID: 12917709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation between circulating leptin levels and lipid lipoproteins in postmenopausal women administered hormone replacement therapy.
    Kanda T; Ichikawa S; Sumino H; Sakamaki T; Nakamura T; Tsukui S; Nara M; Kobayashi I; Tamura J
    Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):179-85. PubMed ID: 11484873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?
    Heikkinen AM; Niskanen L; Ryynänen M; Komulainen MH; Tuppurainen MT; Parviainen M; Saarikoski S
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):402-7. PubMed ID: 9974425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women.
    Binder EF; Birge SJ; Kohrt WM
    J Am Geriatr Soc; 1996 Mar; 44(3):231-6. PubMed ID: 8600189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone replacement therapy on office and ambulatory blood pressure in Japanese hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kanda T; Sakamaki T; Kurabayashi M
    Hypertens Res; 2003 May; 26(5):369-76. PubMed ID: 12887127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.
    Heikkinen AM; Tuppurainen MT; Niskanen L; Komulainen M; Penttilä I; Saarikoski S
    Eur J Endocrinol; 1997 Nov; 137(5):495-502. PubMed ID: 9405029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of dietary intervention alone or combined with hormone replacement therapy in postmenopausal women with hypercholesterolemia in Seoul, Korea.
    Jung K; Kim S; Woo J; Chang Y
    Eur J Nutr; 2002 Jun; 41(3):101-7. PubMed ID: 12111046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
    Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
    Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
    Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
    Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
    Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
    Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.